Vicente LLP Psychedelics & Emerging Therapies Update: April 2024
Apr 12, 2024
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Apr 12, 2024
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Dec 19, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Oct 26, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Oct 11, 2023
Watch this live session on Wednesday, October 11 at 1 p.m. ET. The session will feature Vicente LLP’s director of economics and research, Andrew Livingston, and the firm’s Michigan practice leader, Travis Copenhaver, as they discuss Michigan cannabis market trends and opportunities that will help your business to better adapt, strategize, and navigate changing market conditions.
Sep 11, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Sep 11, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
By Shawn Hauser
Aug 31, 2023
The federal government formally acknowledged the medical use and low potential of abuse for cannabis, with the US Department of Health and Human Services recommending that cannabis be rescheduled to Schedule III under the Controlled Substances Act. While placement in Schedule III still criminalizes commercial cannabis activity at the federal level, it is a significant step on the path to ending prohibition. This rescheduling would eliminate the application of 280E tax penalties, reduce the level of criminal liability for cannabis-related activity, reduce barriers to research, legitimize the industry through gaining credibility and engagement by physicians and the medical community, and support a growing industry for the American economy.
Jul 12, 2023
Mushrooms are having a moment! Watch this session to learn about current and future business opportunities in the growing world of adaptogenic and functional mushrooms.
Jul 7, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Apr 19, 2023
Watch this Vicente LLP session for insights on current CRA enforcement trends and best practices for running a compliant cannabis business in Michigan.
By Krissy Atterholt
Mar 30, 2023
Regulatory enforcement against Michigan cannabis licensees has increased significantly since mid-2022. Read this article for a breakdown of the number of actions, types of penalties, and categories of non-compliance resulting in enforcement.
Mar 9, 2023
Join Vicente partner Travis Copenhaver and Michigan cannabis dispensary owner Mario Porter during a Rootwurks webinar on March 15 to learn the latest compliance and regulatory tips that come with running a cannabis company in Michigan.
By Charles Alovisetti, Sahar Ayinehsazian
Mar 3, 2023
Given the wide variety of available functional/adaptogenic mushroom product forms, producers and consumers should be aware of the significant differences in regulations for food, food additives, and dietary supplements.
By Krissy Atterholt
Feb 14, 2023
Michigan leads the Midwest in affording its communities local protection for psychedelic-based activities. This article gives a breakdown of notable moments in Michigan's psychedelic legislative history.
By Catie Wightman
Feb 13, 2023
In recent years, several CBD companies faced product liability lawsuits brought by consumers. Many of these cases were dismissed without prejudice or stayed until the FDA takes action to regulate CBD products. Now that the FDA said it will not take action to regulate CBD, could these cases be revived?
Feb 9, 2023
The FDA decided not to regulate CBD, denied three citizen petitions requesting CBD rulemaking or other FDA action, and announced it is now up to Congress to step in. Watch this webinar and learn what this means for your hemp-derived cannabinoids business.
By Andrea Golan
Jan 6, 2023
Minnesota hemp companies are being sued by the Minnesota Board of Pharmacy for selling high-THC hemp-derived edibles that allegedly contained 100 milligrams of hemp-derived THC per gummy bear and were intentionally marketed in a manner that is appealing to children. What standards may lower consumer safety risks for these products?
Dec 8, 2022
Watch this session on-demand for a discussion on the cannabis landscape and emerging opportunities in Michigan, Minnesota, Illinois, Ohio, North Dakota, South Dakota, and Wisconsin.
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
By Shane Pennington
Nov 9, 2022
What outcomes are possible from the impending administrative process to reconsider cannabis’s schedule I status? What are the implications of those various possible outcomes? And how should we all proceed in light of it all?
By Krissy Atterholt
Oct 28, 2022
Complying with Michigan's marijuana packaging and labeling laws can be challenging to navigate if you don't pay close attention to the rules. If a product's packaging is not compliant, some potential remedies are available to bring the product back into compliance.
By Krissy Atterholt
Oct 28, 2022
Cannabis packaging and labeling requirements vary across markets and product types, so it’s critical that your packaging and labeling are compliant with state-specific regulations. Read this article to know what information needs to be on marijuana product packaging in Michigan.
By Shane Pennington
Oct 21, 2022
To appreciate the gravity of the President’s scheduling directive and what could happen next, you need to understand (1) how the administrative process the President has set in motion will actually work and (2) how the agencies in charge have used it to affirm and reaffirm cannabis’s schedule I1 status repeatedly throughout the Comprehensive Drug Abuse Prevention and Control Act of 1970’s (“CSA”) history. Those topics are covered in this article.
By Shane Pennington
Oct 21, 2022
President Biden’s scheduling directive is enormously important. In fact, if permitted to run its course, it could revolutionize federal drug control law to a far greater degree than any of the many pending cannabis legalization bills.
By Catie Wightman, Ariane Beckman
Aug 11, 2022
The FDA is cracking down on companies making unlawful drug or disease claims about their products relating to CBD by recently issuing several warning letters to address these compliance violations.
By Travis Copenhaver
Jul 29, 2022
Michigan cannabis licensing is broken up into three steps: prequalification, municipal approval, and state facility approval. The first major hurdle every licensee must go through is the prequalification process.
Jul 28, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
May 17, 2022
Watch this VS live session for a timely discussion exploring intoxicating hemp-derived products.
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
Apr 4, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Michelle Bodian, Jace Pohlman
Mar 30, 2022
The FDA and FTC are working together to target fraudulent COVID-19 claims made by CBD companies. Seven CBD product companies received warning letters. Read this article for a look into what to do—or not do—to avoid a warning.
By Travis Copenhaver
Mar 24, 2022
Michigan's MRA recently announced the Class A Marihuana Microbusiness License. This new microbusiness license differs from the original in several interesting ways, which may create a more profitable business model.
Aug 25, 2021
Vote for the panel "Sue 'n the DEA: Breaking the 50-Year NIDA Monopoly," featuring Shane Pennington to be included in SXSW 2022!
Aug 25, 2021
Vote for the panel "Sue 'n the DEA: Breaking the 50-Year NIDA Monopoly," featuring Shane Pennington to be included in SXSW 2022!
By Shawn Hauser
Aug 25, 2021
Recent NDIN notification objections from the FDA give us more insight into the agency's factors differentiating "full spectrum" hemp from CBD.
Aug 11, 2021
With a new Administration and Congress, changes in personnel at FDA, and new safety data being published, is 2021 the year when CBD will come out from under the FDA shadows to be legally marketed in all 50 states?
By Shawn Hauser
Jul 22, 2021
In this article, we’ll look at the history of CBD regulation in the United States, the trends that are dominating CBD regulation in 2021, and some of the state-specific regulations in the largest states.
Mar 29, 2021
Vicente Sederberg is monitoring local, state, and federal responses to the coronavirus (COVID-19) and how they may impact cannabis businesses, service providers, and consumers.
By Jerrico Perez
Aug 21, 2020
Vicente Sedeberberg LLP continues to identify exclusive licensing opportunities for our clients. With more winning merit-based applications than any other law firm in the country, our team’s work ethic, dedication, and experience can help elevate your application above the competition.
By Corey Cox
May 28, 2020
The CBD-based medicine, Epidiolex, was descheduled by the DEA and is no longer a controlled substance. What are the implications of this change and what, if anything, does it mean for CBD products in general?
By Sahar Ayinehsazian and Kelsey Middleton
May 28, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on cannabis businesses, service providers, and consumers in Michigan.
By Jerrico Perez
May 13, 2020
Vicente Sedeberberg LLP continues to identify exclusive licensing opportunities for our clients. With more winning merit-based applications than any other law firm in the country, our team’s work ethic, dedication, and experience can help elevate your application above the competition.
Mar 9, 2020
You received your Michigan cannabis license. Now what? Join VS and Cannabis Legal Group on March 25 to learn about how to take your business to the next level with private financing.
May 8, 2019
Barton Morris, of counsel at Vicente Sederberg and founder of Cannabis Legal Group, VS's strategic partner in Michigan, was selected to be a member of Attorney General Dana Nessel's marijuana legal workgroup.